# Chloroquine Alone or in Combination for Malaria in Children in Malawi

> **NCT00379821** · PHASE3 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 640 (actual)

## Conditions studied

- Plasmodium Falciparum Infection

## Interventions

- **DRUG:** Atovaquone-proguanil
- **DRUG:** Artesunate
- **DRUG:** Azithromycin
- **DRUG:** Chloroquine

## Key facts

- **NCT ID:** NCT00379821
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2009-08
- **Final completion:** 2012-09
- **Target enrollment:** 640 (ACTUAL)
- **Last updated:** 2014-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00379821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00379821, "Chloroquine Alone or in Combination for Malaria in Children in Malawi". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT00379821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*